Thrive Capital

Thrive Capital Thrive Capital, founded by Josh Kushner, manages $25B+ in AUM with Fund X targeting $6-8B. Thrive IX split $5B between $4B late-stage and $1B early-stage. Josh Kushner was named to TIME's 100 Most Influential People in AI in 2025. The defining bet is AI: Thrive led OpenAI's $6.6B round in October 2024 and continued support through 2025. The AI portfolio also includes Isomorphic Labs (Alphabet's drug discovery spinout) and Anysphere (Cursor). A $522M gain on Carvana in May 2025 dem